The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU Hematology & Medical Oncology Review 2019
C

KU ASCO 2019 Review of SCLC, Early & Locally Advanced NSCLC: Year of Neoadjuvant Therapy and Checkpoint Inhibitors

By KU Hematology & Medical Oncology Review 2019 FEATURING Corey Langer
By KU Hematology & Medical Oncology Review 2019 FEATURING Corey Langer
1,616 views
August 2, 2019
Comments 1
Login to view comments. Click here to Login

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip
Lung
15:47

KU ASCO 2019 Review of SCLC, Early & Locally Advanced NSCLC: Year of…

KU Hematology & Medical Oncology Review 2019

C. Langer

1.6K views
22:33

KU ASCO 2019 Review of Recurrent / Metastatic NSCLC: Wild Type, KN00…

KU Hematology & Medical Oncology Review 2019

C. Langer

900 views